Evaluation of Zoledronic Acid as a Single Agent or as an Adjuvant to Chemotherapy in High Grade Osteosarcoma (ZOL)

Clinical Trial ID NCT00691236

PubWeight™ 5.06‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00691236

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Current therapeutic strategies and novel approaches in osteosarcoma. Cancers (Basel) 2013 1.42
2 Trial watch: Chemotherapy with immunogenic cell death inducers. Oncoimmunology 2012 1.33
3 Bone Sarcomas in Pediatrics: Progress in Our Understanding of Tumor Biology and Implications for Therapy. Paediatr Drugs 2015 0.86
4 Osteosarcoma: Cells-of-Origin, Cancer Stem Cells, and Targeted Therapies. Stem Cells Int 2016 0.81
5 Bone Tumor Environment as a Potential Therapeutic Target in Ewing Sarcoma. Front Oncol 2015 0.78
Next 100